10 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp05061 | P369-CTL-A2xFVB | KIFGSLAFL | Synthetic Peptide | Antiangiogenis; Immune regulation | Peptide dose curve assay | N202.A2 | Tumor | 8% Inhibition at 10-10 M |
| dbacp05062 | P369-CTL-A2xFVB | KIFGSLAFL | Synthetic Peptide | Antiangiogenis; Immune regulation | Peptide dose curve assay | N202.A2 | Tumor | 25% Inhibition at 10-9 M |
| dbacp05063 | P369-CTL-A2xFVB | KIFGSLAFL | Synthetic Peptide | Antiangiogenis; Immune regulation | Peptide dose curve assay | N202.A2 | Tumor | 80% Inhibition at 10-8 M |
| dbacp05064 | P369-CTL-A2xFVB | KIFGSLAFL | Synthetic Peptide | Antiangiogenis; Immune regulation | Peptide dose curve assay | N202.A2 | Tumor | 85% Inhibition at 10-7 M |
| dbacp05065 | P369-CTL-A2xFVB | KIFGSLAFL | Synthetic Peptide | Antiangiogenis; Immune regulation | Peptide dose curve assay | N202.A2 | Tumor | 92% Inhibition at 10-6 M |
| dbacp05066 | P369-CTL-A2xneu | KIFGSLAFL | Synthetic Peptide | Antiangiogenis; Immune regulation | Peptide dose curve assay | N202.A2 | Tumor | 0.1% Inhibition at 10-10 M |
| dbacp05067 | P369-CTL-A2xneu | KIFGSLAFL | Synthetic Peptide | Antiangiogenis; Immune regulation | Peptide dose curve assay | N202.A2 | Tumor | 1% Inhibition at 10-9 M |
| dbacp05068 | P369-CTL-A2xneu | KIFGSLAFL | Synthetic Peptide | Antiangiogenis; Immune regulation | Peptide dose curve assay | N202.A2 | Tumor | 5% Inhibition at 10-8 M |
| dbacp05069 | P369-CTL-A2xneu | KIFGSLAFL | Synthetic Peptide | Antiangiogenis; Immune regulation | Peptide dose curve assay | N202.A2 | Tumor | 10% Inhibition at 10-7 M |
| dbacp05070 | P369-CTL-A2xneu | KIFGSLAFL | Synthetic Peptide | Antiangiogenis; Immune regulation | Peptide dose curve assay | N202.A2 | Tumor | 20% Inhibition at 10-6 M |